Correlation Between Lyell Immunopharma and Unicycive Therapeutics
Can any of the company-specific risk be diversified away by investing in both Lyell Immunopharma and Unicycive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyell Immunopharma and Unicycive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lyell Immunopharma and Unicycive Therapeutics, you can compare the effects of market volatilities on Lyell Immunopharma and Unicycive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyell Immunopharma with a short position of Unicycive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyell Immunopharma and Unicycive Therapeutics.
Diversification Opportunities for Lyell Immunopharma and Unicycive Therapeutics
-0.64 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Lyell and Unicycive is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Lyell Immunopharma and Unicycive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unicycive Therapeutics and Lyell Immunopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyell Immunopharma are associated (or correlated) with Unicycive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unicycive Therapeutics has no effect on the direction of Lyell Immunopharma i.e., Lyell Immunopharma and Unicycive Therapeutics go up and down completely randomly.
Pair Corralation between Lyell Immunopharma and Unicycive Therapeutics
Given the investment horizon of 90 days Lyell Immunopharma is expected to under-perform the Unicycive Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Lyell Immunopharma is 1.05 times less risky than Unicycive Therapeutics. The stock trades about -0.45 of its potential returns per unit of risk. The Unicycive Therapeutics is currently generating about 0.45 of returns per unit of risk over similar time horizon. If you would invest 45.00 in Unicycive Therapeutics on September 15, 2024 and sell it today you would earn a total of 26.00 from holding Unicycive Therapeutics or generate 57.78% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Lyell Immunopharma vs. Unicycive Therapeutics
Performance |
Timeline |
Lyell Immunopharma |
Unicycive Therapeutics |
Lyell Immunopharma and Unicycive Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Lyell Immunopharma and Unicycive Therapeutics
The main advantage of trading using opposite Lyell Immunopharma and Unicycive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyell Immunopharma position performs unexpectedly, Unicycive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unicycive Therapeutics will offset losses from the drop in Unicycive Therapeutics' long position.Lyell Immunopharma vs. Cullinan Oncology LLC | Lyell Immunopharma vs. Monte Rosa Therapeutics | Lyell Immunopharma vs. Revolution Medicines | Lyell Immunopharma vs. Nkarta Inc |
Unicycive Therapeutics vs. Puma Biotechnology | Unicycive Therapeutics vs. Iovance Biotherapeutics | Unicycive Therapeutics vs. Day One Biopharmaceuticals | Unicycive Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
Global Correlations Find global opportunities by holding instruments from different markets | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
CEOs Directory Screen CEOs from public companies around the world |